Actonel “Drug Holidays” May Carry Increased Hip Fracture Risks: Study
Taking a holiday from bone-strengthening drugs like Actonel and Fosamax may increase the risk of hip fractures, according to the findings of a new study.
Tag Archives: Actonel
-
-
Study Questions Whether Fosamax And Similar Bone Drugs Provide Benefits After Seven Years of Use
A new study reveals that Fosamax and similar osteoporosis drugs failed to provide any benefits in preventing hip fractures after seven years of use.
-
Fosamax, Similar Bone Drugs, Linked To Increased Risk of Macular Degeneration: Study
A new study links continuous use of bisphosphonates, like Fosamax and Boniva, to a vision disorder known as wet age-related macular degeneration.
-
Fosamax Hip Fracture Risk Identified in New Report
A new study suggests that bone-strengthing drugs like Fosamax may increase the risk hip fractures among elderly users.
-
Bisphosphonates Linked To Atrial Fibrillation Risk in New Study
A new study finds a link between Fosamax and Atrial Fibrillation six years after federal researchers dismissed such a connection.
-
Side Effects of Bisphosphonates Increase Risk of Atrial Fibrillation: Study
Fosamax and similar drugs may increase the risk of atrial fibrillation, according to a new study.
-
Lawsuit Filed Over Femur Fracture From Use of Actonel and Fosamax
An Illinois woman has filed a lawsuit against the manufacturers of Fosamax and Actonel, alleging that side effects of the osteoporosis drugs caused her to suffer a sudden femur fracture.
-
Fosamax Risks Outweigh Benefit for Osteopenia: Consumer Reports
Women with low bone density that is not severe enough to be considered osteoporosis, should avoid medications like Fosamax, according to Consumer Reports, as the benefits provided by the treatment…
-
Actonel Lawsuit Filed Over Sudden Femur Fracture
A Louisiana woman has filed a lawsuit against Procter & Gamble, Aventis and Warner Chilcott alleging that side effects of Actonel, an osteoporosis drug, caused her to suffer a sudden…
-
FDA Suggests Consumers Use Fosamax, Actonel For 3 to 5 Years
Federal drug regulators are suggesting that consumers consider limiting the use of popular osteoporosis medications, such as Fosamax, Actonel, Boniva and other bisphophonates, to between three and five years, allowing…
